Acrux Limited

ASX (AUD): Acrux Limited (ACR)

Last Price

0.016

Today's Change

0.00 (0.00%)

Day's Change

0.016 - 0.016

Trading Volume

336,397

Profile
ACR

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Michael John Kotsanis BSc, GradDipBus, MBus Michael John Kotsanis BSc, GradDipBus, MBus

Full Time Employees:  43 43

IPO Date:  2004-09-29 2004-09-29

CIK: 

ISIN:  AU000000ACR3 AU000000ACR3

CUSIP:  Q0093N109 Q0093N109

Beta:  0.87 0.87

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of adult males who have low or no testosterone. It also provides estradiol sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause. The company was incorporated in 1998 and is based in West Melbourne, Australia.

Address

103-113, Stanley Street,
West Melbourne, VIC 3003, AU

61 3 8379 0100

http://www.acrux.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment